1. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives;Brufsky;Oncologist,2008
2. Aromatase inhibitors and bone loss;Perez;Oncology (Williston Park),2006
3. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients;Geisler;Clin. Cancer Res.,1998
4. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer;Geisler;Br. J. Cancer,1996
5. In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer;Dowsett;Clin. Cancer Res.,1995